Cream Containing Sericin and Turmeric in Psoriasis Patients

Launched by CHULALONGKORN UNIVERSITY · Jun 28, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new cream that contains sericin (a protein from silk) and turmeric to see how well it helps patients with psoriasis, a skin condition that causes red, scaly patches. In the study, each participant's psoriasis lesion will be divided in half. One half will receive the new cream, while the other half will be treated with a standard steroid cream for comparison. Participants will use the creams twice a day for eight weeks. The researchers will check how well the treatments work by looking at the severity of the psoriasis and how much it affects the participants' quality of life.

To be eligible for the trial, you must be over 18 years old and have psoriasis covering less than 10% of your body. It's important that you haven’t used any topical treatments on your psoriasis for at least two weeks before the trial. The study is open to everyone, regardless of gender. However, individuals with certain health issues, allergies to the ingredients, other skin diseases, or who are pregnant or breastfeeding cannot participate. If you join the study, you will attend regular check-ups to monitor your progress and any side effects. This trial is currently not recruiting participants yet, but it aims to provide new insights into treating psoriasis in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age over 18 years
• • Patients with body surface area of psoriasis lesion less than 10, have psoriasis area and severity index less than 10 , and no lesion at face, hands,feet, and genital area
• • No topical application on psoriasis lesion at least 2 weeks
• • Willing to attend the study
• Exclusion Criteria:
• • Uncontrolled diseases
• • Allergic to sericin turmeric and steroid
• • Other skin diseases
• • Pregnancy and lactation